Utilize este identificador para referenciar este registo:
https://hdl.handle.net/10216/118213Registo completo
| Campo DC | Valor | Idioma |
|---|---|---|
| dc.creator | Freitas-Junior, JCM | - |
| dc.creator | Andrade-da-Costa, J | - |
| dc.creator | Silva, M | - |
| dc.creator | Pinho, SS | - |
| dc.date.accessioned | 2019-01-08T17:30:03Z | - |
| dc.date.available | 2019-01-08T17:30:03Z | - |
| dc.date.issued | 2017 | - |
| dc.identifier.issn | 1661-6596 | - |
| dc.identifier.uri | https://repositorio-aberto.up.pt/handle/10216/118213 | - |
| dc.description.abstract | The insulin/insulin-like growth factor (IGF) system in mammals comprises a dynamic network of proteins that modulate several biological processes such as development, cell growth, metabolism, and aging. Dysregulation of the insulin/IGF system has major implications for several pathological conditions such as diabetes and cancer. Metabolic changes also culminate in aberrant glycosylation, which has been highlighted as a hallmark of cancer. Changes in glycosylation regulate every pathophysiological step of cancer progression including tumour cell-cell dissociation, cell migration, cell signaling and metastasis. This review discusses how the insulin/IGF system integrates with glycosylation alterations and impacts on cell behaviour, metabolism and drug resistance in cancer. | - |
| dc.description.sponsorship | Financial support from Portugal: Institute of Molecular Pathology and Immunology of University of Porto (IPATIMUP) integrates the i3S research unit, which is partially supported by the Portuguese Foundation for Science and Technology (FCT). This article is a result of the project NORTE-01-0145-FEDER-000029, supported by the Norte Portugal Regional Programme (NORTE 2020) under the PORTUGAL 2020 Partnership Agreement through the European Regional Development Fund (ERDF). This work was also funded by FEDER—Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020—Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020, and by Portuguese funds through FCT—Fundação para a Ciência e a Tecnologia/ Ministério da Ciência, Tecnologia e Inovação in the framework of the project (POCI-01/0145-FEDER-016601). Financial support from Brazil: Ministério da Saúde and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), under the project 336/13. | - |
| dc.language.iso | eng | - |
| dc.publisher | MDPI | - |
| dc.relation.ispartof | International Journal of Molecular Sciences, vol.18(9). pii: E1921 | - |
| dc.rights | openAccess | - |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
| dc.subject | Animals | - |
| dc.subject | Glycosylation | - |
| dc.subject | Humans | - |
| dc.subject | Insulin/genetics | - |
| dc.subject | Insulin/metabolism | - |
| dc.subject | Insulin-Like Growth Factor I/genetics | - |
| dc.subject | Insulin-Like Growth Factor I/metabolism | - |
| dc.subject | Neoplasms/genetics | - |
| dc.subject | Neoplasms/metabolism | - |
| dc.subject | Neoplasms/pathology | - |
| dc.subject | Polysaccharides/metabolism | - |
| dc.subject | Regulatory Sequences, Nucleic Acid/genetics | - |
| dc.subject | Signal Transduction/genetics | - |
| dc.subject | Signal Transduction/physiology | - |
| dc.title | Glycans as regulatory elements of the insulin/IGF system: Impact in cancer progression | - |
| dc.type | Artigo em Revista Científica Internacional | - |
| dc.contributor.uporto | Instituto de Investigação e Inovação em Saúde | - |
| dc.identifier.doi | 10.3390/ijms18091921 | - |
| dc.relation.publisherversion | https://www.mdpi.com/1422-0067/18/9/1921 | - |
| Aparece nas coleções: | I3S - Artigo em Revista Científica Internacional | |
Ficheiros deste registo:
| Ficheiro | Descrição | Tamanho | Formato | |
|---|---|---|---|---|
| INT J MOL SCIENCES 2017.pdf | 1.21 MB | Adobe PDF | ![]() Ver/Abrir |
Este registo está protegido por Licença Creative Commons
